Company intelligence / Profile preview

Eden Capital

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Eden Capital is a New York-based private equity firm founded in 2015 that invests in middle-market companies. The firm is not a drug developer or biopharma operating company; instead, it backs businesses in sectors including healthcare services, business services, technology, and education. In healthcare, Eden Capital appears focused on services and training-related businesses rather than therapeutic R&D. The company partners with founders, owners, and management teams to scale businesses through operational support, strategic guidance, and acquisitions. For a biotech analyst, the key point is that Eden Capital is healthcare-adjacent as an investor, not a therapeutics company with a clinical pipeline.

Industry: Investors

Beyond the preview

Go deeper on Eden Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eden Capital.

Explore the full profile